TrialNeuro-oncology2023

Randomized phase III study of high-dose methotrexate and whole-brain radiotherapy with/without temozolomide for newly diagnosed primary CNS lymphoma: JCOG1114C.

Kazuhiko Mishima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.